Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm

被引:12
|
作者
Nowill, Alexandre E. [1 ]
de Campos-Lima, Pedro O. [2 ,3 ]
机构
[1] Univ Estadual Campinas, Integrated Ctr Pediat OncoHaematol Res, BR-13083210 Campinas, SP, Brazil
[2] Boldrini Childrens Ctr, 1270 Gabriel Porto St, BR-13083210 Campinas, SP, Brazil
[3] Univ Estadual Campinas, Inst Biol, Funct & Mol Biol Grad Program, BR-13083865 Campinas, SP, Brazil
来源
JOURNAL OF IMMUNOLOGY | 2020年 / 205卷 / 10期
关键词
INTERLEUKIN-1 RECEPTOR ANTAGONIST; REACTIVE LYMPH-NODES; SEVERE SEPSIS; SEPTIC SHOCK; BCG VACCINATION; DOUBLE-BLIND; PHASE-III; CELLS; THERAPY; EFFICACY;
D O I
10.4049/jimmunol.2000892
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which rapidly became a pandemic of global proportions. Sepsis is commonly present with high lethality in the severe forms of the disease. The virus-induced cytokine storm puts the immune system in overdrive at the expense of the pathogen-specific immune response and is likely to underlie the most advanced COVID-19 clinical features, including sepsis-related multiple organ dysfunction as well as the pathophysiological changes found in the lungs. We review the major therapeutic strategies that have been considered for sepsis and might be amenable to repurposing for COVID-19. We also discuss two different immunization strategies that have the potential to confer antiviral heterologous protection: innate-induced trained immunity and adaptive-induced immune response resetting.
引用
收藏
页码:2566 / 2575
页数:10
相关论文
共 50 条
  • [1] Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
    Pelaia, Corrado
    Calabrese, Cecilia
    Garofalo, Eugenio
    Bruni, Andrea
    Vatrella, Alessandro
    Pelaia, Girolamo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 16
  • [2] Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
    Liu, Tong
    Feng, Meng
    Wen, Zexin
    He, Yijie
    Lin, Wei
    Zhang, Min
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 5475 - 5487
  • [3] Fatal heart arrhythmia associated with enterovirus cardiac infection and SARS-CoV-2-induced cytokine storm
    Callon, Domitille
    N'Guyen, Yohan
    Fornes, Paul
    Andreoletti, Laurent
    PATHOLOGY, 2024, 56 (03) : 434 - 437
  • [4] Cytokine storm induced by SARS-CoV-2
    Song, Peipei
    Li, Wei
    Xie, Jianqin
    Hou, Yanlong
    You, Chongge
    CLINICA CHIMICA ACTA, 2020, 509 : 280 - 287
  • [5] Cellular immune states in SARS-CoV-2-induced disease
    Mortezaee, Keywan
    Majidpoor, Jamal
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia
    Schneider, Coursen W.
    Penney, Scott W.
    Helfrich, Alison M.
    Hartman, Kip R.
    Lieuw, Kenneth
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (06) : E788 - E790
  • [7] SARS-CoV-2-induced SIADH: a novel cause of hyponatremia
    Kleybolte, Johannes
    Storek, Benjamin
    Hegner, Bjoern
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (03): : 301 - 304
  • [8] SARS-CoV-2-induced cytokine storm drives prolonged testicular injury and functional impairment in mice that are mitigated by dexamethasone
    Giannakopoulos, Stefanos
    Pak, Jin
    Bakse, Jackson
    Ward, Monika A.
    Nerurkar, Vivek R.
    Tallquist, Michelle D.
    Verma, Saguna
    PLOS PATHOGENS, 2025, 21 (01)
  • [9] Adaptive immune cells are necessary for SARS-CoV-2-induced pathology
    Imbiakha, Brian
    Sahler, Julie M.
    Buchholz, David W.
    Ezzatpour, Shahrzad
    Jager, Mason
    Choi, Annette
    Monreal, Isaac A.
    Byun, Haewon
    Adeleke, Richard Ayomide
    Leach, Justin
    Whittaker, Gary
    Dewhurst, Stephen
    Rudd, Brian D.
    Aguilar, Hector C.
    August, Avery
    SCIENCE ADVANCES, 2024, 10 (01)
  • [10] SARS-CoV-2 and lung injury: Dysregulation of immune response but not hyperimmune response as in "cytokine storm syndrome"
    Ocal, Serpil
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (01): : 13 - 16